Empyrean Capital Partners’s KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share KAHC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding KAHC.WS
AFM
LP
GC
AC
RCM
AGC
SBLIC
KSCM
GRIM
Empyrean Capital Partners's KAHC.WS Position: Q2 2022 in Review
Empyrean Capital Partners sold out of KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (KAHC.WS) in Q2 2022, closing a stake of 500,000 shares — an estimated $330K sold.
Empyrean Capital Partners first reported a position in KAHC.WS in Q3 2021 and held it in 3 quarters. The position peaked at $499K in Q4 2021. 80 funds tracked by Wall St. Rank hold KAHC.WS as of Q2 2022.
- Empyrean Capital Partners reported no remaining KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
- Empyrean Capital Partners sold 500,000 KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q2 2022, an estimated $330K.
- Empyrean Capital Partners first reported a position in KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 3 quarters.
- Empyrean Capital Partners's KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $499K in Q4 2021.
- 80 funds tracked by Wall St. Rank held KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q2 2022.
Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.